Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Embryonic Stem Cells00:57

Embryonic Stem Cells

Embryonic stem (ES) cells were first discovered in mice in 1981 by Martin Evans. In 1998, James Thomson identified a method to isolate embryonic stem cells from humans. Human embryonic stem cells (hESCs) are obtained from 3-5 day old embryos that remain unused after an in vitro fertilization procedure.
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
Embryonic Stem Cells00:58

Embryonic Stem Cells

Embryonic stem (ES) cells are undifferentiated pluripotent cells, meaning they can produce any cell type in the body. This gives them tremendous potential in science and medicine since they can generate specific cell types for use in research or to replace body cells lost due to damage or disease.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Derivation of Human Embryonic Stem Cells.

Methods in molecular biology (Clifton, N.J.)·2017
Same author

Turning Potential Into Action: Using Pluripotent Stem Cells to Understand Heart Development and Function in Health and Disease.

Stem cells translational medicine·2017
Same author

The promises and challenges of exome sequencing in familial, non-syndromic congenital heart disease.

International journal of cardiology·2016
Same author

Large-Scale Production of Cardiomyocytes from Human Pluripotent Stem Cells Using a Highly Reproducible Small Molecule-Based Differentiation Protocol.

Journal of visualized experiments : JoVE·2016
Same author

Derivation of Genea016 human embryonic stem cell line.

Stem cell research·2016
Same author

Derivation of Genea057 human embryonic stem cell line.

Stem cell research·2016

Related Experiment Video

Updated: Jul 6, 2026

Chromosomal Spread Preparation of Human Embryonic Stem Cells for Karyotyping
10:42

Chromosomal Spread Preparation of Human Embryonic Stem Cells for Karyotyping

Published on: September 4, 2009

Karyotypically normal and abnormal human embryonic stem cell lines derived from PGD-analyzed embryos.

Teija Peura1, Alexis Bosman, Omar Chami

  • 1Sydney IVF, Research Department, New South Wales, Australia. teija.peura@stemcellcentre.edu.au

Cloning and Stem Cells
|April 5, 2008
PubMed
Summary

Stem cell lines can be derived from embryos with chromosomal abnormalities, offering new research avenues. Unexpectedly, many derived stem cell lines were normal, highlighting mosaicism and a new source for stem cell research.

More Related Videos

Enrichment and Purging of Human Embryonic Stem Cells by Detection of Cell Surface Antigens Using the Monoclonal Antibodies TG30 and GCTM-2
12:43

Enrichment and Purging of Human Embryonic Stem Cells by Detection of Cell Surface Antigens Using the Monoclonal Antibodies TG30 and GCTM-2

Published on: December 6, 2013

Generation of Human Primordial Germ Cell-like Cells at the Surface of Embryoid Bodies from Primed-pluripotency Induced Pluripotent Stem Cells
12:06

Generation of Human Primordial Germ Cell-like Cells at the Surface of Embryoid Bodies from Primed-pluripotency Induced Pluripotent Stem Cells

Published on: January 11, 2019

Related Experiment Videos

Last Updated: Jul 6, 2026

Chromosomal Spread Preparation of Human Embryonic Stem Cells for Karyotyping
10:42

Chromosomal Spread Preparation of Human Embryonic Stem Cells for Karyotyping

Published on: September 4, 2009

Enrichment and Purging of Human Embryonic Stem Cells by Detection of Cell Surface Antigens Using the Monoclonal Antibodies TG30 and GCTM-2
12:43

Enrichment and Purging of Human Embryonic Stem Cells by Detection of Cell Surface Antigens Using the Monoclonal Antibodies TG30 and GCTM-2

Published on: December 6, 2013

Generation of Human Primordial Germ Cell-like Cells at the Surface of Embryoid Bodies from Primed-pluripotency Induced Pluripotent Stem Cells
12:06

Generation of Human Primordial Germ Cell-like Cells at the Surface of Embryoid Bodies from Primed-pluripotency Induced Pluripotent Stem Cells

Published on: January 11, 2019

Area of Science:

  • Reproductive biology
  • Stem cell research
  • Genetics

Background:

  • Normal karyotype is typically required for stem cell lines.
  • New applications for stem cells with defined chromosomal aneuploidies are emerging.
  • Embryos with chromosomal abnormalities are often discarded.

Purpose of the Study:

  • Investigate stem cell derivation from aneuploid embryos.
  • Explore stem cell derivation from developmentally arrested embryos.
  • Assess the karyotypic status of derived stem cell lines.

Main Methods:

  • Embryo biopsy and preimplantation genetic diagnosis (PGD) using fluorescent in situ hybridization (FISH).
  • Stem cell derivation from PGD-analyzed and non-PGD embryos.
  • Karyotyping of established stem cell lines.

Main Results:

  • Eleven stem cell lines were derived from 41 embryos.
  • Higher success rate from PGD-analyzed embryos (45%) compared to non-PGD embryos (13%).
  • Six of nine lines from aneuploid embryos and both lines from non-PGD embryos were karyotypically normal.
  • Three aneuploid lines (trisomy 5, trisomy 16, isochromosome 13) were derived from PGD embryos, none matching original PGD findings.

Conclusions:

  • Stem cell lines can be produced from PGD-tested and developmentally abnormal embryos, creating specialty lines for aneuploidy research.
  • Mosaicism and normal cell dominance often lead to karyotypically normal stem cell lines from aneuploid embryos.
  • Developmentally abnormal embryos can serve as a novel source for stem cells for research and potential therapeutic use.